Roger B. Lee

1.6k total citations
25 papers, 1.1k citations indexed

About

Roger B. Lee is a scholar working on Obstetrics and Gynecology, Surgery and Reproductive Medicine. According to data from OpenAlex, Roger B. Lee has authored 25 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Obstetrics and Gynecology, 12 papers in Surgery and 12 papers in Reproductive Medicine. Recurrent topics in Roger B. Lee's work include Endometrial and Cervical Cancer Treatments (14 papers), Ovarian cancer diagnosis and treatment (11 papers) and Intraperitoneal and Appendiceal Malignancies (5 papers). Roger B. Lee is often cited by papers focused on Endometrial and Cervical Cancer Treatments (14 papers), Ovarian cancer diagnosis and treatment (11 papers) and Intraperitoneal and Appendiceal Malignancies (5 papers). Roger B. Lee collaborates with scholars based in United States, Australia and Canada. Roger B. Lee's co-authors include Robert C. Park, Thomas F. Rocereto, Thomas W. Burke, John A. Blessing, Virginia L. Brunetto, Michael W. Sill, Russell J. Schilder, Peter G. Rose, Jeffrey G. Bell and Joan L. Walker and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and American Journal of Obstetrics and Gynecology.

In The Last Decade

Roger B. Lee

25 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roger B. Lee United States 16 636 624 343 234 178 25 1.1k
Abbie L. Fields United States 19 454 0.7× 488 0.8× 318 0.9× 243 1.0× 325 1.8× 43 1.2k
James J. Burke United States 17 674 1.1× 984 1.6× 242 0.7× 94 0.4× 267 1.5× 27 1.6k
Masamichi Hiura Japan 16 705 1.1× 750 1.2× 198 0.6× 95 0.4× 251 1.4× 50 1.2k
Kari L. Ring United States 20 406 0.6× 467 0.7× 500 1.5× 150 0.6× 155 0.9× 74 1.3k
Fernando O. Recio United States 19 416 0.7× 350 0.6× 181 0.5× 67 0.3× 371 2.1× 45 994
Vincenzo Dario Mandato Italy 16 296 0.5× 270 0.4× 142 0.4× 88 0.4× 222 1.2× 71 727
Denise Barbuto United States 17 477 0.8× 520 0.8× 90 0.3× 108 0.5× 158 0.9× 20 857
James Kauderer United States 15 567 0.9× 794 1.3× 246 0.7× 62 0.3× 198 1.1× 25 1.2k
Rola H. Ali Kuwait 18 427 0.7× 773 1.2× 188 0.5× 26 0.1× 141 0.8× 50 1.4k
Ahmed Elattar United Kingdom 14 714 1.1× 304 0.5× 465 1.4× 111 0.5× 408 2.3× 32 1.1k

Countries citing papers authored by Roger B. Lee

Since Specialization
Citations

This map shows the geographic impact of Roger B. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger B. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger B. Lee more than expected).

Fields of papers citing papers by Roger B. Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger B. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger B. Lee. The network helps show where Roger B. Lee may publish in the future.

Co-authorship network of co-authors of Roger B. Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Roger B. Lee. A scholar is included among the top collaborators of Roger B. Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger B. Lee. Roger B. Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Olawaiye, Alexander, James Java, Thomas C. Krivak, et al.. (2018). Does adjuvant chemotherapy dose modification have an impact on the outcome of patients diagnosed with advanced stage ovarian cancer? An NRG Oncology/Gynecologic Oncology Group study. Gynecologic Oncology. 151(1). 18–23. 16 indexed citations
3.
Horowitz, Neil S., G. Larry Maxwell, Austin Miller, et al.. (2017). Predictive modeling for determination of microscopic residual disease at primary cytoreduction: An NRG Oncology/Gynecologic Oncology Group 182 Study. Gynecologic Oncology. 148(1). 49–55. 15 indexed citations
4.
5.
Spriggs, David R., Mark F. Brady, Luis Vaccarello, et al.. (2007). Phase III Randomized Trial of Intravenous Cisplatin Plus a 24- or 96-Hour Infusion of Paclitaxel in Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study. Journal of Clinical Oncology. 25(28). 4466–4471. 41 indexed citations
6.
Sutton, Gregory P., Brian N. Bundy, Tapan Kumar Roy, et al.. (2005). Adjuvant whole abdominal irradiation in clinical stages I and II papillary serous or clear cell carcinoma of the endometrium: A phase II study of the Gynecologic Oncology Group. Gynecologic Oncology. 100(2). 349–354. 69 indexed citations
7.
8.
Muggia, Franco M., John A. Blessing, Michael Method, et al.. (2004). Evaluation of vinorelbine in persistent or recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecologic Oncology. 92(2). 639–643. 53 indexed citations
9.
Blessing, John A., et al.. (2003). Activity of paclitaxel as second-line chemotherapy in endometrial carcinoma: a gynecologic oncology group study. Gynecologic Oncology. 88(3). 277–281. 134 indexed citations
10.
Asbury, Robert F., Virginia L. Brunetto, Roger B. Lee, Gary C. Reid, & Thomas F. Rocereto. (2002). Goserelin Acetate as Treatment for Recurrent Endometrial Carcinoma. American Journal of Clinical Oncology. 25(6). 557–560. 53 indexed citations
11.
Rose, Peter G., et al.. (2000). A Phase II Trial of Anastrozole in Advanced Recurrent or Persistent Endometrial Carcinoma: A Gynecologic Oncology Group Study. Gynecologic Oncology. 78(2). 212–216. 144 indexed citations
12.
Peters, William A., et al.. (1992). Intraperitoneal P-32 is not an effective consolidation therapy after a negative second-look laparotomy for epithelial carcinoma of the ovary. Gynecologic Oncology. 47(2). 146–149. 19 indexed citations
13.
Hammar, Samuel P., Samuel J. Insalaco, Roger B. Lee, et al.. (1992). Amphicrine Carcinoma of the Uterine Cervix. American Journal of Clinical Pathology. 97(4). 516–522. 9 indexed citations
14.
Greer, Benjamin E., David C. Figge, Hisham K. Tamimi, Joanna M. Cain, & Roger B. Lee. (1990). Stage IA2 squamous carcinoma of the cervix: Difficult diagnosis and therapeutic dilemma. American Journal of Obstetrics and Gynecology. 162(6). 1406–1411. 24 indexed citations
15.
Lee, Roger B., et al.. (1990). Surgical complications of obese patients with endometrial carcinoma. Gynecologic Oncology. 39(2). 171–174. 68 indexed citations
16.
Lee, Roger B., Thomas W. Burke, & Robert C. Park. (1990). Estrogen replacement therapy following treatment for stage I endometrial carcinoma. Gynecologic Oncology. 36(2). 189–191. 108 indexed citations
17.
Lee, Roger B., et al.. (1989). Evaluation of Serum Haptoglobin Levels in Patients with Adnexal Masses. Military Medicine. 154(5). 234–236. 1 indexed citations
18.
Lee, Roger B., et al.. (1984). Malignant melanoma of the vagina: A case report of progression from preexisting melanosis. Gynecologic Oncology. 19(2). 238–245. 26 indexed citations
19.
Lee, Roger B. & Robert C. Park. (1981). Bladder dysfunction following radical abdominal hysterectomy. Gynecologic Oncology. 11(3). 304–308. 6 indexed citations
20.
Lee, Roger B., et al.. (1980). Minilaparotomy Under Local Anesthesia for Outpatient Sterilization: A Preliminary Report. Fertility and Sterility. 33(2). 129–134. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Abbie L. Fields Breakdown of academic impact, for papers by James J. Burke Breakdown of academic impact, for papers by Masamichi Hiura Breakdown of academic impact, for papers by Kari L. Ring Breakdown of academic impact, for papers by Fernando O. Recio Breakdown of academic impact, for papers by Vincenzo Dario Mandato Breakdown of academic impact, for papers by Denise Barbuto Breakdown of academic impact, for papers by James Kauderer Breakdown of academic impact, for papers by Rola H. Ali Breakdown of academic impact, for papers by Ahmed Elattar
Rankless by CCL
2026